| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_19b258f0f5ef6176e8fea7ab85a99573 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-346
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-315
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3231
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-113 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-712
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 |
| filingDate |
2022-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4bf76043180895805d68acf11d529c13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80e3c1cc77c20890dbc928938220b880
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e2d16a7bf5ce4888e0b4084cd084012 |
| publicationDate |
2022-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022200632-A1 |
| titleOfInvention |
Microrna-134 inhibitors |
| abstract |
The present invention provides novel highly potent antisense oligonucleotides. Such compounds are useful for making pharmaceutical compositions for treatment of a range of diseases where modulation of miR-134 activity is beneficial, including neurological diseases such as epilepsy. |
| priorityDate |
2021-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |